首页> 外文期刊>Animal Pharm Weekly Briefing >Embion set to commercialize first prebiotic by early 2020
【24h】

Embion set to commercialize first prebiotic by early 2020

机译:Embion设置为第一生命起源以前的商业化2020年初

获取原文
获取原文并翻译 | 示例
           

摘要

A recent injection of funding will help Swiss start-up Embion Technologies bring its first prebiotic to market at the beginning of 2020.Embion's prebiotic ingredients are designed to improve animal health and performance through the use of sustainablefood side-stream feedstocks. The company's technology extracts soluble prebiotic oligosaccharides from plant byproduct feedstocks for microbiome nutrition, through a catalytic platform. This process enables the selection of sugar or derivatives that arereleased as final products.
机译:最近的一次注入的资金将帮助瑞士先启动Embion技术使其生命起源以前的市场开始2020.通过改善动物健康和性能使用sustainablefood侧流原料。从植物可溶性生命起源以前的低聚糖副产品饲料微生物营养,通过催化平台。使糖或衍生品的选择arereleased作为最终产品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号